Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

2Seventy Bio stock price, quote, forecast and news

TSVT
US9013841070

Price

4.81
Today +/-
+0
Today %
+0 %
P

2Seventy Bio Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into 2Seventy Bio, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by 2Seventy Bio from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects 2Seventy Bio’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of 2Seventy Bio. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into 2Seventy Bio’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing 2Seventy Bio’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on 2Seventy Bio’s growth potential.

2Seventy Bio Revenue, EBIT and net profit per share

Date2Seventy Bio Revenue2Seventy Bio EBIT2Seventy Bio Net Income
2029e170.85 M undefined0 undefined46.15 M undefined
2028e180.66 M undefined17.95 M undefined37.76 M undefined
2027e120.35 M undefined-4.61 M undefined12.06 M undefined
2026e104.81 M undefined-7.81 M undefined-12.24 M undefined
2025e83.83 M undefined-61.12 M undefined-31.77 M undefined
2024e63.26 M undefined-136.78 M undefined-117.27 M undefined
2023100.39 M undefined-216.94 M undefined-217.57 M undefined
202291.5 M undefined-253.5 M undefined-254.2 M undefined
202154.5 M undefined-303.8 M undefined-292.2 M undefined
2020248.1 M undefined-138.2 M undefined-120.1 M undefined
201944.3 M undefined-340.7 M undefined-320.6 M undefined
201854.6 M undefined-203.4 M undefined-199.7 M undefined

2Seventy Bio Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)EBIT (M)EBIT MARGIN (%)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
2018201920202021202220232024e2025e2026e2027e2028e2029e
544424854911006383104120180170
--18.52463.64-78.2368.529.89-37.0031.7525.3015.3850.00-5.56
98.1593.1897.5896.3081.3283.00------
5341242527483000000
-203-340-138-303-253-216-137-58-29-4170
-375.93-772.73-55.65-561.11-278.02-216.00-217.46-69.88-27.88-3.339.44-
-199-320-120-292-254-217-117-31-12123746
-60.80-62.50143.33-13.01-14.57-46.08-73.50-61.29-200.00208.3324.32
23.423.423.423.535.649.28000000
------------
Details

Keystats

ⓘ

Revenue and Growth

The 2Seventy Bio Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the 2Seventy Bio is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of 2Seventy Bio provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand 2Seventy Bio's financial health and stability.

Assets

2Seventy Bio's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that 2Seventy Bio must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of 2Seventy Bio after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into 2Seventy Bio's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
201820192020202120222023
-199-320-120-292-254-217
131213161110
000000
-335-1513-352
841261151108269
1500000
000000
-146-207-67-207-237-166
-50-59-22-19-22-13
-50-59-22151143
000343457
000000
-100000
19426790354166127
19726790354166127
300000
000000
000163-594
-197.05-267.73-90.05-226.61-259.97-180.72
000000

2Seventy Bio stock margins

The 2Seventy Bio margin analysis displays the gross margin, EBIT margin, as well as the profit margin of 2Seventy Bio. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for 2Seventy Bio.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the 2Seventy Bio's sales revenue. A higher gross margin percentage indicates that the 2Seventy Bio retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the 2Seventy Bio's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the 2Seventy Bio's total revenue generated. When comparing the revenue margin year over year, investors can gauge the 2Seventy Bio's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the 2Seventy Bio. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the 2Seventy Bio's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

2Seventy Bio Margin History

2Seventy Bio Gross margin2Seventy Bio Profit margin2Seventy Bio EBIT margin2Seventy Bio Profit margin
2029e83.15 %0 %27.01 %
2028e83.15 %9.94 %20.9 %
2027e83.15 %-3.83 %10.02 %
2026e83.15 %-7.46 %-11.67 %
2025e83.15 %-72.91 %-37.89 %
2024e83.15 %-216.22 %-185.38 %
202383.15 %-216.1 %-216.73 %
202281.86 %-277.05 %-277.81 %
202195.41 %-557.43 %-536.15 %
202097.82 %-55.7 %-48.41 %
201993.23 %-769.07 %-723.7 %
201898.35 %-372.53 %-365.75 %

2Seventy Bio Stock Sales Revenue, EBIT, Earnings per Share

The 2Seventy Bio earnings per share therefore indicates how much revenue 2Seventy Bio has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue 2Seventy Bio earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates 2Seventy Bio's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of 2Seventy Bio’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating 2Seventy Bio's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

2Seventy Bio Revenue, EBIT and net profit per share

Date2Seventy Bio Sales per Share2Seventy Bio EBIT per share2Seventy Bio Earnings per Share
2029e3.32 undefined0 undefined0.9 undefined
2028e3.51 undefined0 undefined0.73 undefined
2027e2.34 undefined0 undefined0.23 undefined
2026e2.04 undefined0 undefined-0.24 undefined
2025e1.63 undefined0 undefined-0.62 undefined
2024e1.23 undefined0 undefined-2.28 undefined
20232.04 undefined-4.4 undefined-4.42 undefined
20222.57 undefined-7.12 undefined-7.14 undefined
20212.32 undefined-12.93 undefined-12.43 undefined
202010.6 undefined-5.91 undefined-5.13 undefined
20191.89 undefined-14.56 undefined-13.7 undefined
20182.33 undefined-8.69 undefined-8.53 undefined

2Seventy Bio business model

2Seventy Bio is one of the most popular companies on Eulerpool.com.

2Seventy Bio historical P/E ratio, EBIT, and P/S ratio.

2Seventy Bio shares outstanding

The number of shares was 2Seventy Bio in 2023 — This indicates how many shares 49.276 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue 2Seventy Bio earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates 2Seventy Bio's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of 2Seventy Bio’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating 2Seventy Bio's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Unfortunately, there are currently no price targets and forecasts available for 2Seventy Bio.

2Seventy Bio latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
3/31/2024-0.83 -1.01  (-21.92 %)2024 Q1
12/31/2023-1.01 -1.11  (-9.91 %)2023 Q4
9/30/2023-1.05 -1  (4.66 %)2023 Q3
6/30/2023-1.09 -0.83  (23.59 %)2023 Q2
3/31/2023-1.22 -1.08  (11.27 %)2023 Q1
12/31/2022-1.64 -0.6  (63.37 %)2022 Q4
9/30/2022-1.84 -1.76  (4.41 %)2022 Q3
6/30/2022-2.32 -2.02  (12.99 %)2022 Q2
3/31/2022-2.1 -3.2  (-52.93 %)2022 Q1
12/31/2021-2.89 -2.55  (11.85 %)2021 Q4
1
2

2Seventy Bio list of shareholders

%
Name
Stocks
Change
Date
8.70 % Goldman Sachs & Company, Inc.4,470,6123,969,94812/31/2023
7.75 % The Vanguard Group, Inc.3,985,770258,37312/31/2023
7.71 % Morgan Stanley & Co. LLC3,965,5612,793,86712/31/2023
6.81 % BlackRock Institutional Trust Company, N.A.3,501,210-149,20912/31/2023
4.86 % Baker Bros. Advisors LP2,497,526012/31/2023
4.54 % Millennium Management LLC2,335,272-1,313,89312/31/2023
3.89 % Casdin Capital, LLC2,000,000817,3773/28/2024
3.41 % Madison Avenue Partners LP1,754,788260,66312/31/2023
2.91 % Engine Capital Management, LP1,494,3041,152,43412/31/2023
2.82 % Dafna Capital Management, LLC1,447,465012/31/2023
1
2
3
4
5
...
10

2Seventy Bio Executives and Management Board

Mr. Nick Leschly50
2Seventy Bio President, Chief Executive Officer, Director (since 2021)
Compensation 6.08 M
Dr. Philip Gregory52
2Seventy Bio Chief Scientific Officer
Compensation 2.53 M
Mr. William Baird51
2Seventy Bio Chief Financial Officer, Chief Operating Officer
Compensation 2.44 M
Ms. Denice Torres63
2Seventy Bio Independent Director
Compensation 330,508
Mr. Daniel Lynch65
2Seventy Bio Independent Chairman of the Board
Compensation 327,571
1
2

2Seventy Bio Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
Biogen Stock
Biogen
SupplierCustomer0,790,810,770,84--
Roivant Sciences Stock
Roivant Sciences
SupplierCustomer0,650,690,250,86--
Regeneron Pharmaceuticals Stock
Regeneron Pharmaceuticals
SupplierCustomer0,580,290,74-0,15--
Bristol-Myers Squibb Stock
Bristol-Myers Squibb
SupplierCustomer0,50-0,250,10-0,74--
Alexandria Real Estate Stock
Alexandria Real Estate
SupplierCustomer0,360,870,770,82--
Gritstone bio Stock
Gritstone bio
SupplierCustomer0,070,880,450,92--
Showa Denko Stock
Showa Denko
SupplierCustomer0,070,500,250,55--
Inhibrx Stock
Inhibrx
SupplierCustomer-0,030,810,670,94--
Novo Nordisk B Stock
Novo Nordisk B
SupplierCustomer-0,520,630,20-0,04--
MediGene Stock
MediGene
SupplierCustomer-0,620,460,610,07--
1

Most common questions regarding 2Seventy Bio

What is the P/E ratio of 2Seventy Bio 2024?

The 2Seventy Bio P/E ratio is -2.02.

What is the P/S ratio of 2Seventy Bio 2024?

The 2Seventy Bio P/S ratio is 3.75.

What is the AlleAktien quality score of 2Seventy Bio?

The AlleAktien quality score for 2Seventy Bio is 2/10.

What is the revenue of 2Seventy Bio 2024?

The expected 2Seventy Bio revenue is 63.26 M USD.

How high is the profit of 2Seventy Bio 2024?

The expected 2Seventy Bio profit is -117.27 M USD.

What is the business model of 2Seventy Bio

No history available for 2Seventy Bio.

What is the 2Seventy Bio dividend?

2Seventy Bio pays a dividend of 0 USD distributed over payouts per year.

How often does 2Seventy Bio pay dividends?

The dividend cannot currently be calculated for 2Seventy Bio or the company does not pay out a dividend.

What is the 2Seventy Bio ISIN?

The ISIN of 2Seventy Bio is US9013841070.

What is the 2Seventy Bio ticker?

The ticker of 2Seventy Bio is TSVT.

How much dividend does 2Seventy Bio pay?

Over the past 12 months, 2Seventy Bio paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, 2Seventy Bio is expected to pay a dividend of 0 USD.

What is the dividend yield of 2Seventy Bio?

The current dividend yield of 2Seventy Bio is .

When does 2Seventy Bio pay dividends?

2Seventy Bio pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of 2Seventy Bio?

2Seventy Bio paid dividends every year for the past 0 years.

What is the dividend of 2Seventy Bio?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is 2Seventy Bio located?

2Seventy Bio is assigned to the 'Health' sector.

Wann musste ich die Aktien von 2Seventy Bio kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of 2Seventy Bio from 7/31/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/31/2024.

When did 2Seventy Bio pay the last dividend?

The last dividend was paid out on 7/31/2024.

What was the dividend of 2Seventy Bio in the year 2023?

In the year 2023, 2Seventy Bio distributed 0 USD as dividends.

In which currency does 2Seventy Bio pay out the dividend?

The dividends of 2Seventy Bio are distributed in USD.

All fundamentals about 2Seventy Bio

Our stock analysis for 2Seventy Bio Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of 2Seventy Bio Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.